Business & Management

Business & Management Experts

Cameron Black

Business Management
Repare Therapeutics


Cameron joined Repare Therapeutics in mid-2016 to lead the drug discovery efforts on newly identified synthetic lethal targets. Prior to this, he spent 18 years at Merck Frosst during which time he was responsible for the identification of seven drug candidates. He led both the discovery and early clinical development of the cathepsin K inhibitor odanacatib, a once-weekly treatment for osteoporosis.

Research Interest

Business Management

Global Experts from Canada

Global Experts in Subject

Share This Profile